» Articles » PMID: 31781258

Therapeutic Effect and Mechanism Study of Var. Injection to Acute Blood Stasis Using Metabolomics Based on UPLC-Q/TOF-MS

Overview
Date 2019 Nov 30
PMID 31781258
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In traditional Chinese medicine theory, blood stasis syndrome (BSS), characterized by blood flow retardation and blood stagnation, is one of the main pathologic mechanisms and clinical syndromes of cardiovascular diseases (CVDs). var. injection (RWCI) is made from dry roots and stems of RWC via the processes of decoction, alcohol precipitation, filtration, and dilution. Studies indicated the extracts of RWC could alleviate CVDs; however, the mechanism had not been illustrated. In the present study, the acute blood stasis rat model was established to investigate the pathogenesis of BSS and the therapeutic mechanism of RWCI against BSS. Hemorheological parameters (whole blood viscosity and plasma viscosity) and inflammatory factors (TNF- and IL-6) were used to evaluate the success of the BSS rat model and RWCI efficacy. 14 and 33 differential metabolites were identified from plasma and urine samples using the metabolomics approach based on ultrahigh-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. The results of multivariate analysis displayed that there were significant separations among model, control, and treatment groups, but the high-dose RWCI treatment group was closer to the control group. 9 perturbed metabolic pathways were related to BSS's development and RWCI intervention. 5 metabolic pathways (arachidonic acid metabolism, linoleic acid metabolism, alpha-linolenic acid metabolism, retinol metabolism, and steroid hormone biosynthesis) showed apparent correlations. These differential metabolites and perturbed metabolic pathways might provide a novel view to understand the pathogenesis of BSS and the pharmacological mechanism of RWCI.

Citing Articles

The therapeutic role of Jingchuan tablet on ischaemic cerebral stroke via the HIF-1α/EPO/VEGFA signalling pathway.

Zhang Y, Liu Q, Zhang T, Wang H, Fu Y, Wang W Pharm Biol. 2022; 60(1):2110-2123.

PMID: 36269045 PMC: 9590438. DOI: 10.1080/13880209.2022.2134430.


Quality Evaluation of Randomized Controlled Trials of Species: A Systematic Review.

Li X, Chen W, Xu Y, Liang Z, Hu H, Wang S Evid Based Complement Alternat Med. 2021; 2021:9989546.

PMID: 34306163 PMC: 8266448. DOI: 10.1155/2021/9989546.


High-Throughput Metabolomics Discovers Metabolic Biomarkers and Pathways to Evaluating the Efficacy and Exploring Potential Mechanisms of Osthole Against Osteoporosis Based on UPLC/Q-TOF-MS Coupled With Multivariate Data Analysis.

Si Z, Zhou S, Shen Z, Luan F Front Pharmacol. 2020; 11:741.

PMID: 32670052 PMC: 7326133. DOI: 10.3389/fphar.2020.00741.


Metabolite Profile Changes in Different Regions of Rat Brain Affected by .

Liao Z, Li S, Huang Y, Luo X, Zhong Y, Ji Y Evid Based Complement Alternat Med. 2020; 2020:8358039.

PMID: 32419830 PMC: 7201840. DOI: 10.1155/2020/8358039.

References
1.
Zhao Y, Cheng X, Wei F, Bai X, Tan X, Lin R . Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E). J Proteome Res. 2012; 12(2):692-703. DOI: 10.1021/pr3007792. View

2.
Krumsiek J, Bartel J, Theis F . Computational approaches for systems metabolomics. Curr Opin Biotechnol. 2016; 39:198-206. DOI: 10.1016/j.copbio.2016.04.009. View

3.
Samanidou V, Pantazidou K, Kovatsi L, Njau S, Livanos A . A simple HPLC method for the simultaneous determination of two selective serotonin reuptake inhibitors and two serotonin-norepinephrine reuptake inhibitors in hair, nail clippings, and cerebrospinal fluid. J Sep Sci. 2012; 35(7):839-45. DOI: 10.1002/jssc.201100849. View

4.
Liu P, Duan J, Wang P, Qian D, Guo J, Shang E . Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine. Mol Biosyst. 2012; 9(1):77-87. DOI: 10.1039/c2mb25238d. View

5.
Meng H, Liu Y, Lai L . Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation. Acc Chem Res. 2015; 48(8):2242-50. DOI: 10.1021/acs.accounts.5b00226. View